Pharmacists in Fayetteville, Arkansas
188 Pharmacists found in Fayetteville
Margaret Sorrells, R.PH.
Pharmacist
3909 N Mall Ave Attn:pharmacy, Fayetteville, AR 72703
479-443-9267
Mark Andrew Kostelnik, PHARMD, BCPS
Pharmacist
375 E Millsap Rd Ste 3, Fayetteville, AR 72703
918-809-7822 479-445-6032
Matthew Brian Jones, PHARM D
Pharmacist
3545 N Shiloh Dr, Fayetteville, AR 72703
479-443-5628 479-439-6363
Dr. Matthew Bedford Calhoun, PHARMD
Pharmacist
524 S School Ave, Fayetteville, AR 72701
479-251-7685
Megan R Onder, PHARMD
Pharmacist - Psychiatric
1100 N College Ave, Fayetteville, AR 72703
479-443-4301
Dr. Melissa Anne Waterhouse, PHARMD
Pharmacist
1100 N College Ave # 119, Fayetteville, AR 72703
479-443-4301
Mrs. Melissa Morrison Brown, PHARM.D.
Pharmacist
2515 E. Huntsville Road, Fayetteville, AR 72701
479-443-3411 479-443-3412
Michael D. Scribner, P.D.
Pharmacist
3380 N Futrall Dr, Suite #2, Fayetteville, AR 72703
479-443-9200
Dr. Michele Lea Walker, PHARM.D.
Pharmacist - Geriatric
1100 N College Ave, Fayetteville, AR 72703
417-891-4901
Dr. Michelle Lynn Balli, PHARMD, BCACP
Pharmacist
1100 N College Ave, Fayetteville, AR 72703
479-443-4301
Dr. Michelle Rushano, PHARMD
Pharmacist - Pharmacotherapy
1100 N College Ave, Fayetteville, AR 72703
479-443-4301
Dr. Michelle Leclerc, PHARMD
Pharmacist
300 E Township St, Fayetteville, AR 72703
479-582-0098 479-582-2864
Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.